MeiraGTx (MGTX) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Meeting commenced with introductions of board members, executive officers, and the independent auditor.
Agenda and rules of conduct were outlined, with instructions for shareholder participation and Q&A.
Record date for voting was set as April 21, 2026, and notice of meeting was confirmed as distributed.
Board and executive committee updates
Board members and executive officers were introduced, including the CEO, CFO/COO, and General Counsel.
Shareholder proposals
Two proposals were presented: election of three Class 2 directors and ratification of the independent auditor.
Shareholders were invited to submit questions on the proposals before voting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from MeiraGTx
- Late-stage gene therapies advance with pivotal xerostomia data, XLRP filings, and major partnerships.MGTX
Jefferies Global Healthcare Conference 20268 Jun 2026 - Late-stage pipeline and riboswitch platform drive transformative therapies for major unmet needs.MGTX
Corporate presentation4 Jun 2026 - Regained RPGR rights and late-stage pipeline progress position for near-term commercialization.MGTX
Bank of America Global Healthcare Conference 202621 May 2026 - Q1 2026 net loss rose to $46.3M; FDA breakthrough, bota-vec deal, and $100M raise drive pipeline.MGTX
Q1 202614 May 2026 - Director elections, auditor ratification, and robust governance highlight this year's proxy.MGTX
Proxy filing30 Apr 2026 - Director elections and auditor ratification headline the June 2026 annual meeting agenda.MGTX
Proxy filing30 Apr 2026 - AAV-AQP1/AAV-hAQP1 delivers durable, transformative benefit for persistent xerostomia.MGTX
KOL event16 Apr 2026 - Pivotal gene therapy programs and Riboswitch platform drive late-stage pipeline and market growth.MGTX
Corporate presentation16 Apr 2026 - Breakthrough designations, strategic deals, and improved financials drive pipeline and outlook.MGTX
Q4 202526 Mar 2026